FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009796329> ?p ?o ?g. }

• W2009796329 endingPage "2187" @default.
• W2009796329 startingPage "2181" @default.
• W2009796329 abstract "Due to devastating prognosis, novel therapies are needed for pancreatic cancer. We are in preparation for a human clinical trial of a conditionally replicative adenovirus (CRAd) we developed. While most patients in the target population are receiving either gemcitabine or 5-fluorouracil chemotherapy, the combination with CRAd has not yet been studied. This study was designed to evaluate combination therapies with CRAd and current standard chemotherapies in pancreatic cancer. When the combination therapy was tested in vitro, gemcitabine pretreatment showed a synergistic effect in two out of four cell lines whereas CRAd followed by gemcitabine exhibited a synergistic effect in one cell line. With 5-fluorouracil, pretreatment with 5-fluorouracil produced a synergistic effect in three cell lines whereas post-treatment was synergistic in only one cell line. These effects were not fully explained by either induction of cyclooxygenase (Cox) 2 activity or adenoviral receptors with chemotherapeutics. In in vivo analyses with Hs766T xenograft, 5-fluorouracil slightly improved the CRAd antitumor effect but it was not significant. Pretreatment with gemcitabine embodied a significant tumor reduction compared with single therapy with gemcitabine. The most significant antitumor effect occurred when tumors were treated with 5/3COX2CRAdF and subsequent gemcitabine (P = 0.001 vs gemcitabine alone, P = 0.012 vs 5/3COX2CRAdF alone) at day 12. In MIA Paca-2, pretreatments with either 5-fluorouracil or gemcitabine improved the CRAd therapeutic effect when administered before CRAd injection (P = 0.03 and P = 0.01, respectively). These experiments indicate the possible benefit of combination therapies, and thus it is not necessary to interrupt chemotherapeutics when receiving CRAd therapy." @default.
• W2009796329 created "2016-06-24" @default.
• W2009796329 creator A5022987623 @default.
• W2009796329 creator A5034809982 @default.
• W2009796329 creator A5040557156 @default.
• W2009796329 creator A5048788127 @default.
• W2009796329 date "2009-11-01" @default.
• W2009796329 modified "2023-09-30" @default.
• W2009796329 title "Combination of conditionally replicative adenovirus and standard chemotherapies shows synergistic antitumor effect in pancreatic cancer" @default.
• W2009796329 cites W133524052 @default.
• W2009796329 cites W1582164157 @default.
• W2009796329 cites W1991711054 @default.
• W2009796329 cites W1994784565 @default.
• W2009796329 cites W2019298966 @default.
• W2009796329 cites W2021070333 @default.
• W2009796329 cites W2022389416 @default.
• W2009796329 cites W2043103956 @default.
• W2009796329 cites W2049309316 @default.
• W2009796329 cites W2050115564 @default.
• W2009796329 cites W2089081183 @default.
• W2009796329 cites W2102666707 @default.
• W2009796329 cites W2128562119 @default.
• W2009796329 cites W2157806347 @default.
• W2009796329 cites W2158543140 @default.
• W2009796329 cites W2164193797 @default.
• W2009796329 cites W2165260654 @default.
• W2009796329 cites W4241956099 @default.
• W2009796329 doi "https://doi.org/10.1111/j.1349-7006.2009.01289.x" @default.
• W2009796329 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4569096" @default.
• W2009796329 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19689475" @default.
• W2009796329 hasPublicationYear "2009" @default.
• W2009796329 type Work @default.
• W2009796329 sameAs 2009796329 @default.
• W2009796329 citedByCount "19" @default.
• W2009796329 countsByYear W20097963292012 @default.
• W2009796329 countsByYear W20097963292013 @default.
• W2009796329 countsByYear W20097963292014 @default.
• W2009796329 countsByYear W20097963292015 @default.
• W2009796329 countsByYear W20097963292017 @default.
• W2009796329 countsByYear W20097963292018 @default.
• W2009796329 countsByYear W20097963292020 @default.
• W2009796329 crossrefType "journal-article" @default.
• W2009796329 hasAuthorship W2009796329A5022987623 @default.
• W2009796329 hasAuthorship W2009796329A5034809982 @default.
• W2009796329 hasAuthorship W2009796329A5040557156 @default.
• W2009796329 hasAuthorship W2009796329A5048788127 @default.
• W2009796329 hasBestOaLocation W20097963291 @default.
• W2009796329 hasConcept C121608353 @default.
• W2009796329 hasConcept C126322002 @default.
• W2009796329 hasConcept C143998085 @default.
• W2009796329 hasConcept C150903083 @default.
• W2009796329 hasConcept C207001950 @default.
• W2009796329 hasConcept C2776694085 @default.
• W2009796329 hasConcept C2776999253 @default.
• W2009796329 hasConcept C2778397455 @default.
• W2009796329 hasConcept C2780210213 @default.
• W2009796329 hasConcept C2780258809 @default.
• W2009796329 hasConcept C2780456651 @default.
• W2009796329 hasConcept C502942594 @default.
• W2009796329 hasConcept C71924100 @default.
• W2009796329 hasConcept C82210918 @default.
• W2009796329 hasConcept C86803240 @default.
• W2009796329 hasConcept C98274493 @default.
• W2009796329 hasConceptScore W2009796329C121608353 @default.
• W2009796329 hasConceptScore W2009796329C126322002 @default.
• W2009796329 hasConceptScore W2009796329C143998085 @default.
• W2009796329 hasConceptScore W2009796329C150903083 @default.
• W2009796329 hasConceptScore W2009796329C207001950 @default.
• W2009796329 hasConceptScore W2009796329C2776694085 @default.
• W2009796329 hasConceptScore W2009796329C2776999253 @default.
• W2009796329 hasConceptScore W2009796329C2778397455 @default.
• W2009796329 hasConceptScore W2009796329C2780210213 @default.
• W2009796329 hasConceptScore W2009796329C2780258809 @default.
• W2009796329 hasConceptScore W2009796329C2780456651 @default.
• W2009796329 hasConceptScore W2009796329C502942594 @default.
• W2009796329 hasConceptScore W2009796329C71924100 @default.
• W2009796329 hasConceptScore W2009796329C82210918 @default.
• W2009796329 hasConceptScore W2009796329C86803240 @default.
• W2009796329 hasConceptScore W2009796329C98274493 @default.
• W2009796329 hasIssue "11" @default.
• W2009796329 hasLocation W20097963291 @default.
• W2009796329 hasLocation W20097963292 @default.
• W2009796329 hasLocation W20097963293 @default.
• W2009796329 hasLocation W20097963294 @default.
• W2009796329 hasOpenAccess W2009796329 @default.
• W2009796329 hasPrimaryLocation W20097963291 @default.
• W2009796329 hasRelatedWork W1481973004 @default.
• W2009796329 hasRelatedWork W1828873947 @default.
• W2009796329 hasRelatedWork W1973185040 @default.
• W2009796329 hasRelatedWork W1982243606 @default.
• W2009796329 hasRelatedWork W1994784565 @default.
• W2009796329 hasRelatedWork W2011206688 @default.
• W2009796329 hasRelatedWork W2016080258 @default.
• W2009796329 hasRelatedWork W2021070333 @default.
• W2009796329 hasRelatedWork W2022389416 @default.
• W2009796329 hasRelatedWork W2056459029 @default.
• W2009796329 hasRelatedWork W2063512646 @default.
• W2009796329 hasRelatedWork W2091889088 @default.

• next